Form 4: Marvell CFO Sells Shares Under 10b5-1 Plan

Sentiment:

Statement of Changes in Beneficial Ownership


Marvell Technology, Inc. Chief Financial Officer, Willem A. Meintjes, reported the sale of 4,000 shares of common stock under a pre-arranged 10b5-1 trading plan.

Summary

  • Willem A. Meintjes, Chief Financial Officer of Marvell Technology, Inc., sold 4,000 shares of common stock.
  • The transactions occurred on May 15, 2026.
  • These sales were executed under a Rule 10b5-1 trading plan adopted on January 9, 2026.
  • The shares were sold at a weighted average price of $175.24, with individual sales ranging from $173.85 to $177.08.
  • Following these transactions, Meintjes beneficially owns 226,675 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the sale is conducted under a pre-established 10b5-1 plan, which is a standard practice for insiders to diversify their holdings or manage personal finances without implying negative views on the company's prospects.

Negatives

  • Insider selling of company stock, even if pre-planned, can sometimes be perceived negatively by the market.

Risks

  • The filing does not explicitly mention any risks associated with these transactions.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future financial performance.

Management Comments

  • The sales were made pursuant to a 10b5-1 Plan adopted by the Reporting Person on January 9, 2026.
  • The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.85 to $177.08, inclusive.
  • The reporting person undertakes to provide Marvell Technology, Inc. ('Marvell'), any security holder of Marvell, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Industry Context

StockSavvy.ai notes that insider sales under 10b5-1 plans are common and are designed to provide an affirmative defense against accusations of insider trading by establishing a predetermined trading schedule. This filing indicates a routine execution of such a plan by a key executive.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
10b5-1 Plan ExecutionExecution of a pre-arranged trading plan for the sale of equity securities.05/15/2026Standard corporate governance practice to allow insiders to trade securities without violating insider trading rules.

Stakeholder Impact

  • Shareholders: The sale of shares by a key executive may lead to questions about insider confidence, although the 10b5-1 plan mitigates concerns about illegal insider trading.
  • Employees: No direct impact mentioned.
  • Customers: No direct impact mentioned.
  • Suppliers: No direct impact mentioned.
  • Creditors: No direct impact mentioned.

Next Steps

  • The reporting person may continue to execute trades under the 10b5-1 plan.
  • Full information regarding the number of shares sold at each separate price will be provided upon request to Marvell, any security holder, or the SEC staff.

Key Dates

DateDescription
01/09/2026Date the Rule 10b5-1 trading plan was adopted by the Reporting Person.
05/15/2026Date of the reported stock sale transactions.
05/18/2026Date the Form 4 was signed by the Reporting Person (or their attorney-in-fact).

Keywords

Marvell Technology, MRVL, Form 4, Insider Trading, 10b5-1 Plan, Stock Sale, Chief Financial Officer, Willem Meintjes

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.